Effect of Omega-3 Fatty Acids on Kynurenine Metabolism and Mood
Omega-3 Fatty Acids Supplementation on Stress-induced Changes to Kynurenine Metabolism and Mood in Physically Active and Inactive Males
1 other identifier
interventional
80
1 country
1
Brief Summary
The purpose of the current study is to explore the effect of omega-3 fatty acids supplementation on stress-induced changes to kynurenine metabolism and mood. The objectives of this research project are as follows:
- 1.To compare biochemical parameters (KYN and KYNA, markers of oxidative stress, and markers of inflammation) between physically active and inactive males
- 2.To determine the impact of a 3-month supplementation with omega-3 fatty acids on mood, inflammation markers and oxidative stress, and changes in KYN and KYNA
- 3.To determine the impact of the stress manipulation test (TSST) on mood and changes in KYN and KYNA before and after the omega-3 fatty acids supplementation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 20, 2020
CompletedFirst Submitted
Initial submission to the registry
July 14, 2021
CompletedFirst Posted
Study publicly available on registry
August 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedAugust 30, 2022
August 1, 2022
2 years
July 14, 2021
August 28, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Kynurenine pathway and its metabolites
Before the intervention and 12 weeks after the start of the intervention blood samples will be collected from the participants to determine kynurenine pathway and its metabolites, namely Xanthurenic acid \[ng/mL\], Kynurenic acid \[ng/mL\], Kynurenine \[ng/mL\] and 3-Hydroxykynurenine \[ng/mL\]. This will be followed by inducing a stress response with the Trier Social Stress Test (TSST) in both groups of participants. Straight after TSST and one hour after the stress manipulation test Xanthurenic acid \[ng/mL\], Kynurenic acid \[ng/mL\], Kynurenine \[ng/mL\] and 3-Hydroxykynurenine \[ng/mL\] will be reassessed.
3 months
Secondary Outcomes (5)
Mood
3 months
Mood
3 months
Omega-3 fatty acids
3 months
Inflammation markers
3 months
Oxidative stress
3 months
Study Arms (2)
Physically active males
EXPERIMENTALHalf of the study population will consist of long-distance runners with 2-5 years of experience in running and similar times in covering the half-marathon distance.
Physically inactive males
EXPERIMENTALThe other half of the study population will consist of age-matched individuals involved in no regular physical activity.
Interventions
Participants received Omega-3 supplements (NAMEDSPORT) in the form of softgels over a period of 12 weeks. The supplement is certified by the International Fish Oil Standards™ (IFOS™) Program. Daily dose contained a total of 3276 mg of Omega 3 (4000 mg of fish oil of which: EPA 2234mg; DHA 916mg).
Participants will receive a placebo in the form of MCT oil capsules with no effect on the hypothesized outcome.
Eligibility Criteria
You may qualify if:
- long-distance runners with 2-5 years of experience in running and similar times in covering the half-marathon distance
- age-matched individuals involved in no regular physical activity
- must provide a signed informed consent form
You may not qualify if:
- DSM-5 psychiatric diagnoses other than depression and anxiety disorders (American Psychiatric Association, 2013)
- neurological disorders any other serious medical problems
- taking dietary supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Gdansklead
- National Science Centre, Polandcollaborator
Study Sites (1)
Medical University of Gdańsk
Gdansk, 80-210, Poland
Related Publications (2)
Bidzan-Wiacek M, Tomczyk M, Blazek M, Mika A, Antosiewicz J. No Effects of Omega-3 Supplementation on Kynurenine Pathway, Inflammation, Depressive Symptoms, and Stress Response in Males: A Placebo-Controlled Trial. Nutrients. 2024 Oct 31;16(21):3744. doi: 10.3390/nu16213744.
PMID: 39519577DERIVEDTomczyk M, Bidzan-Wiacek M, Kortas JA, Kochanowicz M, Jost Z, Fisk HL, Calder PC, Antosiewicz J. Omega-3 fatty acid supplementation affects tryptophan metabolism during a 12-week endurance training in amateur runners: a randomized controlled trial. Sci Rep. 2024 Feb 19;14(1):4102. doi: 10.1038/s41598-024-54112-x.
PMID: 38374149DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 14, 2021
First Posted
August 30, 2022
Study Start
November 20, 2020
Primary Completion
December 1, 2022
Study Completion
February 1, 2023
Last Updated
August 30, 2022
Record last verified: 2022-08